Precision Medicine and Genomics in Concierge Practice: A Physician's Guide to Integrating Personalized Care Responsibly
URL: /lead/precision-medicine (replaces the current page)
CATEGORY: CMT Leadership Hub · Clinical Innovation · Practice Development
READING TIME: 6–8 minutes
CMT Leadership Hub · Precision Medicine & Genomics · Bringing personalized, preventive, and data-informed care into membership medicine
DISCLAIMER
Educational content only. No product endorsements implied. Content is for informational purposes only and does not constitute medical, legal, or financial advice. Inclusion of any technology, organization, or research does not imply endorsement by CMT. Physicians should evaluate all tools and technologies independently and consult qualified clinical, legal, and regulatory advisors before integrating any new service into their practice.
INTRODUCTION
Precision medicine and genomics are no longer distant concepts reserved for academic medical centers and research hospitals. They are becoming practical clinical tools — available to community physicians and, increasingly, to the physicians most structurally positioned to use them well: those practicing in concierge and membership-based care.
The reason is structural, not technological. Precision medicine requires something that traditional high-volume primary care almost never has: time. Time to explain a genomic test result. Time to integrate biomarker data into a longitudinal care plan. Time to have the kind of conversation that turns a genetic risk finding into a meaningful preventive strategy rather than a source of patient anxiety without follow-through.
Membership medicine creates that environment. And that creates an opportunity — not to chase trends, but to lead thoughtfully in an area of medicine that the evidence increasingly supports.
This article examines what precision medicine and genomics mean in the context of concierge practice, what the current evidence supports, what responsible integration looks like, and how three physicians and researchers active in this space are thinking about it.
WHAT PRECISION MEDICINE ACTUALLY MEANS IN PRIMARY CARE
Precision medicine is sometimes framed as a future-state vision — the promise that every patient will eventually receive care tailored to their unique genetic, environmental, and behavioral profile. That framing is partly accurate and partly misleading, because important elements of precision medicine are already in use in primary care settings today.
Precision medicine, also termed stratified, individualised, targeted, or personalised medicine, embraces a rapidly expanding area of research, knowledge, and practice. It brings together two emerging health technologies to deliver better individualised care: the many "-omics" arising from increased capacity to understand the human genome, and "big data" and data analytics, including artificial intelligence. conciergemedicinetoday
Government-driven precision medicine initiatives such as the "All of Us" research program in the U.S. and similar initiatives across the EU have been largely genomics-focused. It has been estimated that by the end of 2025, 52 million genomes will have been sequenced across the globe, most of which will have been performed in North America and Europe, with 40.5 million. MGMA
In the primary care context specifically, precision medicine currently includes several practical applications: pharmacogenomic testing to identify how a patient metabolizes specific medications; polygenic risk score tools that aggregate multiple genetic variants to estimate disease risk; hereditary cancer and cardiovascular risk assessments; and increasingly, whole genome sequencing as a first-line clinical tool rather than a specialist referral.
Examples of precision medicine in current primary care practice include clinical prediction tools that incorporate genomic markers and pharmacogenomic testing. conciergemedicinetoday
For the concierge physician, these tools are not new clinical obligations — they are extensions of what relationship-based medicine already does. A physician who knows a patient's family history deeply, tracks their biomarkers over time, and has the appointment length to explain a risk finding is already practicing in the spirit of precision medicine. Genomic testing and advanced diagnostics add data layers to that foundation.
THE HONEST TENSIONS
Responsible engagement with precision medicine requires acknowledging the tensions in the field — not to discourage adoption, but to ensure that what gets adopted is evidence-based and patient-centered rather than technology-driven.
There is a tension between personalized medicine and population medicine, with a real risk that precision medicine will exacerbate health inequalities and divert funds and attention from basic healthcare requirements, leading to worse health outcomes for many. For concierge physicians, this equity tension is worth sitting with. The structural advantages that make concierge medicine well-suited for precision medicine integration — time, continuity, smaller panels — are the same advantages that make the model inaccessible to patients who cannot afford membership fees. Concierge physicians who integrate precision medicine tools are offering a level of preventive sophistication that most patients in the broader healthcare system cannot access. conciergemedicinetoday
This is not an argument against integration. It is an argument for doing it thoughtfully — with honest patient communication about what the tests can and cannot tell them, without overpromising clinical certainty that the evidence does not yet support, and with attention to how findings are delivered and followed through.
This enthusiasm is tempered by a healthy degree of scepticism, sometimes expressed by the same authors. Some comment that precision medicine is over-hyped. The concierge physician who integrates genomics responsibly is one who reads that scepticism, understands it, and uses it as a guide for what to offer — and what not to. conciergemedicinetoday
WHAT RESPONSIBLE INTEGRATION LOOKS LIKE
CMT's editorial position on precision medicine in concierge practice is consistent with its broader editorial standard: evidence before enthusiasm, relationship before technology, education before recommendation.
The practices that integrate precision medicine well share a set of operational commitments that matter more than which specific tests they offer.
They educate before testing. A genomic test result is only clinically useful if the patient understands what it means, what it doesn't mean, and what — if anything — they should do differently as a result. Concierge physicians have the appointment time to do this well. Many still don't. Pre-test counseling is not optional when the results carry the potential to generate significant patient anxiety or drive unnecessary downstream testing.
They prioritize actionability. The most defensible precision medicine integrations are the ones where a positive or elevated-risk finding has a clear, evidence-based clinical response. Pharmacogenomic testing for commonly prescribed medications. Hereditary cardiovascular risk assessment where statin or screening decisions would change. BRCA and related hereditary cancer risk panels where surveillance or prophylactic intervention options exist. Tests whose results inform a clinical action are categorically different from tests whose results generate data without a clear pathway to do anything with it.
They maintain transparency about uncertainty. Polygenic risk scores, for example, are probabilistic estimates — not diagnoses. A patient with a high polygenic risk score for coronary artery disease has not been told they will have a heart attack. They have been told their genetic profile, combined with population-level data, suggests elevated risk relative to average. That distinction matters enormously in patient communication, and concierge physicians who communicate it clearly build trust in ways that physicians who frame genomic findings as certainties do not.
They keep relationship at the center. Precision medicine tools should clarify care, not complicate it. The best use of a genomic finding in a concierge practice is a deeper, more personalized conversation with a patient who trusts their physician — not a report delivered without context. The technology serves the relationship. The relationship does not serve the technology.
FROM THE FIELD: THREE PERSPECTIVES
Several guests have discussed precision medicine and its application in membership care on the DocPreneur Leadership Podcast and in CMT's coverage. Their perspectives reflect the range of practical experience physicians are encountering as these tools enter community clinical settings.
Dr. Celia Egan, MD, MSCP, DABOM — Director of Obesity Medicine and Metabolic Health at true. Women's Health — has been involved in integrating whole genome sequencing into a complete wellness program, working with Sequencing.com. Her practice's experience offers a real-world example of what it looks like to make genomic testing a clinical workflow rather than an add-on service. The key, in her context, is integration — whole genome sequencing becoming part of a comprehensive wellness assessment rather than a standalone test ordered in isolation.
Sajung Yun, CEO at Predictiv and adjunct professor at Johns Hopkins University, has focused specifically on clinical decision support tools for genomic care — the infrastructure that helps physicians interpret and act on genomic data rather than simply receiving it. His work addresses one of the most practical barriers to precision medicine adoption in primary care: most physicians were not trained to interpret genomic data, and the gap between having a result and knowing what to do with it is where patients are most at risk of being poorly served.
Premal Shah, Ph.D., CEO of MyOme — has examined how genomics is reshaping concierge medicine specifically, looking at how whole genome sequencing can function as a comprehensive preventive health tool within the concierge care context rather than solely as a diagnostic instrument for identified conditions.
These three perspectives share a common thread: the practical integration of precision medicine in concierge care is not primarily a question of which tests to order. It is a question of workflow, counseling, interpretation infrastructure, and clinical context — all of which the concierge model is better positioned to provide than traditional primary care, but none of which happen automatically by virtue of the model alone.
PRACTICAL APPLICATIONS IN CONCIERGE PRACTICE
For physicians considering how to integrate precision medicine tools into their practice, the following categories represent the most evidence-supported entry points as of 2026.
Pharmacogenomics is among the most immediately actionable applications in primary care. Testing for variants in genes like CYP2D6, CYP2C19, and related metabolizing enzymes can meaningfully inform prescribing decisions for a wide range of commonly used medications — antidepressants, antiplatelets, opioids, and more. The clinical utility is clearest when patients are initiating new medications or have experienced unexpected side effects or inadequate therapeutic responses.
Hereditary cardiovascular risk assessment — including testing for familial hypercholesterolaemia, LDLR variants, and related genetic cardiovascular risk factors — has established clinical pathways with clear downstream management implications. Concierge physicians managing patients with strong family histories of premature cardiovascular disease or persistently elevated LDL despite statin therapy are well-positioned to integrate this testing into longitudinal preventive care plans.
Hereditary cancer risk panels — BRCA1/2, Lynch syndrome-associated variants, and related hereditary cancer risk assessments — have the longest evidence base of any genomic testing category in primary care and the clearest clinical action pathways through established surveillance and prophylactic intervention protocols.
Biomarker tracking and longitudinal monitoring — including advanced lipid panels, inflammatory markers, metabolic panels, and continuous or periodic monitoring of clinically relevant biomarkers — is not genomics per se, but is precision medicine in practice. Concierge physicians who track a patient's biomarker trends over years rather than interpreting each result in isolation are practicing the longitudinal, personalized care that precision medicine at its best aspires to.
Whole genome sequencing as a wellness tool — the integration practiced by true. Women's Health and a growing number of forward-looking concierge practices — represents a more comprehensive approach that is becoming clinically feasible as sequencing costs continue to decline. The clinical utility of broad-based genomic sequencing outside of specific diagnostic indications is still being established, and physicians integrating it into wellness programs should communicate that context honestly to patients.
THE LEADERSHIP STANDARD
CMT's editorial position on precision medicine integration in concierge practice reflects the same standard that applies across all of our clinical coverage: evidence before enthusiasm, education before recommendation, relationship before technology.
Precision medicine tools are not a differentiating feature to be listed in marketing materials. They are clinical instruments that carry obligations — to explain, to contextualize, to follow through, and to be honest about what the data can and cannot tell a patient about their future health.
The concierge physicians who integrate these tools most successfully are the ones who use them to go deeper into the relationships they have already built — not to add services for their own sake, but because a patient they know well now has additional information that, in the right hands and with the right explanation, might genuinely change what happens next in their health.
That is what precision medicine at its best actually looks like. Not a test. A conversation. Made possible by the time to have it.
RELATED RESOURCES
Watch: Women's Health Now Adds Whole Genome Sequencing to Its Wellness Program — Dr. Celia Egan & Dr. Brandon Colby, Sequencing.com · youtu.be/eSDRfJ5aHQw
Watch: Evaluating Clinical Decision Support Tools for Genomic Care — Sajung Yun, CEO, Predictiv / Johns Hopkins
Watch: How Genomics Is Reshaping Concierge Medicine — Premal Shah, Ph.D., CEO, MyOme
Read: With Sequencing.com, true. Women's Health Now Incorporates Whole Genome Sequencing Into Their Complete Wellness Program — sequencing.com/blog
SOURCES AND CITATIONS
Evans W, Meslin EM, Kai J, Qureshi N. Precision Medicine — Are We There Yet? A Narrative Review of Precision Medicine's Applicability in Primary Care. Journal of Personalized Medicine. 2024;14(4):418. DOI: 10.3390/jpm14040418. PMC11051552.
Mani S, Lalani SR, Pammi M. Genomics and Multiomics in the Age of Precision Medicine. Pediatric Research. 2025. DOI: 10.1038/s41390-025-04021-0. PMC12106083.
Jamil U et al. Genomic Medicine and Personalized Treatment: A Narrative Review. Annals of Medicine and Surgery. 2025;87(3):1406–1414. DOI: 10.1097/MS9.0000000000002965. PMC11981433.
NIH National Human Genome Research Institute. Precision Medicine Initiative. genome.gov
NIH All of Us Research Program. allofus.nih.gov
Sequencing.com. true. Women's Health Whole Genome Sequencing Integration. sequencing.com/blog
CONTINUE IN THE LEADERSHIP HUB
Leadership Hub · Operations & Compliance · Succession, Valuation & The Next Chapter · DocPreneur Podcast · CMF 2026
Educational content only. No product endorsements implied. Content is for informational purposes only and does not constitute medical, legal, or financial advice. Physicians should evaluate all tools and technologies independently. © 2026 Concierge Medicine Today, LLC. All rights reserved.